{"id":12015,"date":"2021-04-12T09:03:10","date_gmt":"2021-04-12T09:03:10","guid":{"rendered":"https:\/\/tz.investorportal.com.au\/?page_id=12015"},"modified":"2025-07-31T10:37:44","modified_gmt":"2025-07-31T00:37:44","slug":"investor-centre","status":"publish","type":"page","link":"https:\/\/template.reachmarkets.com.au\/investorportal\/","title":{"rendered":"Investor Centre"},"content":{"rendered":"\n<section id=\"banner-header\" class=\"wp-block-gutentor-m3 section-gmd9ab723 gutentor-module gutentor-container-cover has-image-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gm8ccda1c\" class=\"wp-block-gutentor-m3 alignwide section-gm8ccda1c gutentor-module gutentor-container-cover fullwidth\"><div class=\"grid-container\">\n<section id=\"gmae32ad5\" class=\"wp-block-gutentor-m4 section-gmae32ad5 gutentor-module gutentor-advanced-columns align-center\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmd8ad8b\" class=\"wp-block-gutentor-m4-col col-gmd8ad8b gutentor-single-column  grid-lg-4 grid-md-12 grid-12 asx-title\"><div id=\"section-gmd8ad8b\" class=\"section-gmd8ad8b gutentor-col-wrap\">\n<p class=\"has-black-color has-text-color\">ASX code<\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmbb73cf\" class=\"wp-block-gutentor-m4-col col-gmbb73cf gutentor-single-column  grid-lg-4 grid-md-12 grid-12 price-top\"><div id=\"section-gmbb73cf\" class=\"section-gmbb73cf gutentor-col-wrap\">        <div class=\"product-carousel text-center white-color\" data-slick='{\"slidesToShow\":\"6\",\"slidesToScroll\":1,\"arrows\":false,\"dots\":false,\"fade\":false,\"autoplay\":false,\"speed\":1000,\"responsive\":[{\"breakpoint\":991,\"settings\":{\"slidesToShow\":10,\"arrows\":false}},{\"breakpoint\":767,\"settings\":{\"slidesToShow\":10,\"arrows\":false}}]}'>\n            <div class=\"product title\">\n                <div class=\"product-bottom \">\n                <p class=\"product-prices\">\n                    <span  class=\"price-investor\">PTX<\/span><br\/>\n                    <span class=\"title-investor\">ASX code<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom \">\n                <p class=\"product-prices\">\n                    <span data-yourir=\"price\" class=\"price-investor\"><\/span><br\/>\n                    <span class=\"title-investor\">Current price<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                    \n                    <span class=\"price-investor\" data-yourir=\"prevClose\"><\/span><br\/>\n                    <span class=\"title-investor\">Previous Close<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                   \n                    <span class=\"price-investor\" data-yourir=\"pctChange\"><\/span><br\/>\n                     <span class=\"title-investor\">Movement<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n               \n                <span class=\"price-investor\" data-yourir=\"volume\"><\/span><br\/>\n                 <span class=\"title-investor\">Volume<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                   \n                    <span class=\"price-investor\" data-yourir=\"marketCap scale=true\"><\/span><br\/>\n                     <span class=\"title-investor\">Market Cap<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <\/div>\n        \n\n\n<\/div><\/div>\n\n\n\n<div id=\"col-gm2d0902\" class=\"wp-block-gutentor-m4-col col-gm2d0902 gutentor-single-column  grid-lg-4 grid-md-12 grid-12 chart-btn\"><div id=\"section-gm2d0902\" class=\"section-gm2d0902 gutentor-col-wrap\">\n<input class=\"onchart ab-item removc \" type=\"button\" value=\"Show chart\">\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"divMsg\" class=\"wp-block-gutentor-m3 section-gm69b989d gutentor-module gutentor-container-cover has-image-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gmf5d7e8d\" class=\"wp-block-gutentor-m3 alignwide section-gmf5d7e8d gutentor-module gutentor-container-cover fullwidth\"><div class=\"grid-container\">        <script src=\"https:\/\/yourir.info\/3dd816e0350bdd55.js\"><\/script>\n        <script>\n            \/\/ var jExample = jQuery.noConflict();\n            var abc = window.setInterval(function(){\n                if( \/Android|webOS|iPhone|iPad|iPod|BlackBerry|IEMobile|Opera Mini\/i.test(navigator.userAgent) ) {\n                    document.querySelectorAll(\".yourir-chart-xaxis-outside\").forEach(a=>a.style.display = \"none\");\n                }\n            }, 100);\n        <\/script>\n        <section class=\"round-border1\">\n            \n            <div id=\"collapse3\" style=\"min-height: 100px;\">\n                <div class=\"container-fluid container-fluid-shareprice\" id=\"shareprice\">\n                    <div class=\"container container-investor\">\n                        <div class=\"row\" style=\" margin-left: 0; \">\n                            <div class=\"col-sm-12\" style=\"padding: 0px;\">\n                                <div class=\"chart-left col-sm-12\">\n                                    <section class=\"document\" style=\"padding-left:10px;\">\n                                        <div data-yourir=\"priceComparisonChart1 range=6m ismobile=true volume.visible=true news.visible=true announcements.visible=true\">\n                                            <div class=\"price-chart yourir-chart-xaxis-labels-centered-with-tick\" data-yourir=\"plots\">  \n                                            <\/div>\n                                            <div class=\"button-style\" style=\"margin-top: 40px;\">\n                                                <strong>Range<\/strong>\n                                                <button data-yourir=\"range\" value=\"1d\" class=\"range first\">Today<\/button>\n                                                <button data-yourir=\"range\" value=\"5d\" class=\"range \">5 Days<\/button>\n                                                <button data-yourir=\"range\" value=\"1m\" class=\"range\">1 Month<\/button>\n                                                <button data-yourir=\"range\" value=\"3m\" class=\"range\">3 Months<\/button>\n                                                <button data-yourir=\"range\" value=\"6m\" class=\"range yourir-active active\">6 Months<\/button>\n                                                <button data-yourir=\"range\" value=\"ytd\" class=\"range\">YTD<\/button>\n                                                <button data-yourir=\"range\" value=\"1y\" class=\"range\">1 Year<\/button>\n                                                <button data-yourir=\"range\" value=\"2y\" class=\"range\">2 Years<\/button>\n                                                <button data-yourir=\"range\" value=\"5y\" class=\"range\">5 Years<\/button>\n                                                <button data-yourir=\"range\" value=\"99y\" class=\"range last\">max<\/button>\n                                            <\/div>\n                                            <div class=\"button-style\" style=\"margin-top: 20px;\"><strong>Show<\/strong>\n                                                <button data-yourir=\"volume.visible\" class=\"volume first\">Volume<\/button> \n                                                <button data-yourir=\"announcements.visible\" id=\"annou-news\" class=\"news click last\">News<\/button>\n                                            <\/div>\n                                           \n                                        <\/div>\n                                    <\/section>\n                                <\/div>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            \n        <\/section>\n        \n        \n<\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"strategy\" class=\"wp-block-gutentor-m3 section-gm5c34fb5 gutentor-module gutentor-container-cover has-image-bg has-custom-bg alignfull\"><div class=\"grid-container\">        <div class=\"wp-slider enouvo-carousel layout1\" data-slick='{\"slidesToShow\":1,\"slidesToScroll\":1,\"arrows\":true,\"dots\":true,\"fade\":true,\"autoplay\":false,\"speed\":\"1000\",\"responsive\":[{\"breakpoint\":1199,\"settings\":{\"arrows\":false,\"autoplay\":false}},{\"breakpoint\":767,\"settings\":{\"arrows\":true,\"autoplay\":false}}]}' data-height=\"350\" data-heightmb=\"500\">\n                                <div class=\"item\" >\n                        <div class=\"grid-row\">\n                            <div class=\"grid-12 text-center\" style=\"background-image: url(https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/ptx-main-banner-new-min.jpg); background-size: cover; background-repeat: no-repeat; background-position: center\">\n                                <div class=\"item-content\" style=\"max-width: 637px; margin: auto;\">\n                                    <h2 class=\"title \">Investor centre<\/h2>\n                                    <div class=\"content\">Welcome to the Investor Centre. Here you can find all the latest ASX announcements, news, company information and presentations, reports and up-to-the-minute share price and information.<\/div>\n                                    <p><a class=\"wp-btn\" href=\"#\" tabindex=\"0\">Register today<\/a><\/p>                                    \n                                <\/div>\n                            <\/div>\n                        <\/div>  \n                    <\/div>\n                            <\/div>\n        \n<\/div><\/section>\n\n\n\n<section id=\"gm9abeb4c\" class=\"wp-block-gutentor-m3 alignfull section-gm9abeb4c gutentor-module gutentor-container-cover has-color-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gm1d41146\" class=\"wp-block-gutentor-m4 section-gm1d41146 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmf96adb\" class=\"wp-block-gutentor-m4-col col-gmf96adb gutentor-single-column  grid-lg-12 grid-md-12 grid-12 list-menu\"><div id=\"section-gmf96adb\" class=\"section-gmf96adb gutentor-col-wrap\">\n<ul class=\"wp-block-list\">\n<li><a href=\"#company-presentation\">About Prescient Therapeutics<\/a><\/li>\n\n\n\n<li><a href=\"#share-price\">share price<\/a><\/li>\n\n\n\n<li><a href=\"#announcements\">announcements<\/a><\/li>\n\n\n\n<li><a href=\"#webcast\">investor briefing<\/a><\/li>\n\n\n\n<li><a href=\"#media\">Media<\/a><\/li>\n<\/ul>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"introduction\" class=\"wp-block-gutentor-m3 alignwide section-gm6c0c28f gutentor-module gutentor-container-cover d-none announ desktop\"><div class=\"grid-container\">\n<h3 class=\"wp-block-heading\"> Latest announcements <\/h3>\n\n\n        <div data-yourir=\"announcements pageSize=5 startYear=2007\">\n            <div class=\"div-prive-all\">\n              <div class=\"type\">\n                <b>Announcement type: <\/b>\n                <select data-yourir=\"filter\" name=\"filter\" class=\"select-filter\">\n                    <option value=\"\">All types<\/option>\n                    <option value=\"securityHolder\">Security Holder Notices<\/option>\n                    <option value=\"annualReports\">Annual Reports<\/option>\n                    <option value=\"periodicReports\">Periodic Reports<\/option>\n                    <option value=\"dividendNotices\">Dividend Notices<\/option>\n                    <option value=\"companyAdministration\">Company Administration<\/option>\n                    <option value=\"priceSensitive\">Price Sensitive<\/option>\n                    <option value=\"nonProcedural\">Non-Procedural<\/option>\n                <\/select> \n                <\/div>\n                <div class=\"search-input\">\n                  <b>Search Announcements <\/b>\n                  <img decoding=\"async\" src=\"https:\/\/prescienttherapeutics.investorportal.com.au\/wp-content\/uploads\/2021\/09\/search.svg\" class=\"search_icon_image\">\n                  <input type=\"text\" data-yourir=\"search\" placeholder=\"Keyword\" name=\"search\" id=\"input-search\" class=\"input-search\">\n                  \n                <\/div>\n                <div class=\"box50\">\n              <div class=\"price-sensi\">\n                <b>Sensitive <\/b>\n                 <select data-yourir=\"priceSensitiveOnly\" name=\"priceSensitiveOnly\" class=\"select-filter\">\n                  <option value=\"\">Price Sensitive <\/option>\n                      <option value=\"yes\">Yes<\/option>\n                      <option value=\"no\">No<\/option>\n                  <\/select> \n                <!-- <input type=\"checkbox\" data-yourir=\"priceSensitiveOnly\" name=\"priceSensitiveOnly\" class=\"select-checkbox\"> --> \n              <\/div>\n              <div class=\"year\">\n                  <b>Year: <\/b>\n                  <select data-yourir=\"year\" name=\"year\" class=\"select-year\">\n                      <option value=\"none\">All<\/option>\n                      <option value=\"2017\">2017<\/option><option value=\"2018\">2018<\/option><option value=\"2019\">2019<\/option><option value=\"2020\">2020<\/option><option value=\"2021\">2021<\/option><option value=\"2022\">2022<\/option><option value=\"2023\">2023<\/option><option value=\"2024\">2024<\/option><option value=\"2025\">2025<\/option><option value=\"2026\">2026<\/option>                  <\/select> \n                 <\/div>\n                 <\/div>\n               <!--  <div class=\"page-size\">\n                   <b>Page size <\/b>\n                  <select data-yourir=\"pageSize\" name=\"pageSize\" class=\"select-size\">\n                    <option value=\"10\">10<\/option>\n                    <option value=\"20\">20<\/option>\n                    <option value=\"30\">30<\/option>\n                <\/select> \n                <\/div> -->\n                <\/div>\n                <table data-yourir=\"ifnot isEmpty\" style=\"display: table;\" class=\"desktop\">\n                    <tbody data-yourir=\"items\"><tr data-yourir-id=\"ntu.asx\/6A887316\">\n                      <td data-yourir=\"$cur.heading\" class=\"yourir-announcement-heading row1\"><\/td>\n                       <td data-yourir=\"$cur.priceSensitive\" class=\"yourir-price-sensitive row2\"><span class=\"yourir-tooltip-wrapper\"><span class=\"yourir-price-sensitive\"><\/span><span class=\"sen\">Price Sensitive<\/span><\/span><\/td>\n                      <td data-yourir=\"$cur.date format='D MMM, YYYY'\" class=\"date row3\"> \n                      <\/td>\n                    <\/tr>\n                <\/tbody>\n                <\/table>\n                \n                <div class=\"nav\" data-yourir=\"ifnot isEmpty\" style=\"display: block;text-align: center;\">\n                    <div style=\"margin-top: 30px\" class=\"stock-pagination\"> \n                        <button class=\"prevPage\" data-yourir=\"prevPage\" disabled=\"\">\u276c<\/button> \n                        <button data-yourir=\"navPage1\" class=\"yourir-active naviga\"><\/button> \n                        <button data-yourir=\"navPage2\" class=\"naviga\"><\/button> \n                        <button data-yourir=\"navPage3\" class=\"naviga\"><\/button> \n                        <button data-yourir=\"navPage4\" class=\"naviga\"><\/button> \n                        <button class=\"nextPage\" data-yourir=\"nextPage\">\u276d<\/button>\n                    <\/div>\n                <\/div>\n                <div data-yourir=\"if isEmpty\" style=\"display: none;\">\n                    No results\n                <\/div>\n        <\/div>\n        \n\n\n\n<div id=\"section-g1fcd67\" class=\"wp-block-gutentor-e2 section-g1fcd67 gutentor-element gutentor-element-button button-align-left-desktop boxshadow button-ennou\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/share-price-and-announcements\/\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>See all announcements<\/span><\/a><\/span><\/div>\n<\/div><\/section>\n\n\n\n<section id=\"introduction\" class=\"wp-block-gutentor-m3 alignwide section-gmaa56aa4 gutentor-module gutentor-container-cover d-none announ mobile\"><div class=\"grid-container\">\n<h3 class=\"wp-block-heading\"> Latest announcements <\/h3>\n\n\n        <div data-yourir=\"announcements pageSize=5 startYear=2007\">\n            <div class=\"div-prive-all\">\n              <div class=\"type\">\n                <b>Announcement type: <\/b>\n                <select data-yourir=\"filter\" name=\"filter\" class=\"select-filter\">\n                    <option value=\"\">All types<\/option>\n                    <option value=\"securityHolder\">Security Holder Notices<\/option>\n                    <option value=\"annualReports\">Annual Reports<\/option>\n                    <option value=\"periodicReports\">Periodic Reports<\/option>\n                    <option value=\"dividendNotices\">Dividend Notices<\/option>\n                    <option value=\"companyAdministration\">Company Administration<\/option>\n                    <option value=\"priceSensitive\">Price Sensitive<\/option>\n                    <option value=\"nonProcedural\">Non-Procedural<\/option>\n                <\/select> \n                <\/div>\n                <div class=\"search-input\">\n                  <b>Search Announcements <\/b>\n                  <img decoding=\"async\" src=\"https:\/\/prescienttherapeutics.investorportal.com.au\/wp-content\/uploads\/2021\/09\/search.svg\" class=\"search_icon_image\">\n                  <input type=\"text\" data-yourir=\"search\" placeholder=\"Keyword\" name=\"search\" id=\"input-search\" class=\"input-search\">\n                  \n                <\/div>\n                <div class=\"box50\">\n              <div class=\"price-sensi\">\n                <b>Sensitive <\/b>\n                 <select data-yourir=\"priceSensitiveOnly\" name=\"priceSensitiveOnly\" class=\"select-filter\">\n                  <option value=\"\">Price Sensitive <\/option>\n                      <option value=\"yes\">Yes<\/option>\n                      <option value=\"no\">No<\/option>\n                  <\/select> \n                <!-- <input type=\"checkbox\" data-yourir=\"priceSensitiveOnly\" name=\"priceSensitiveOnly\" class=\"select-checkbox\"> --> \n              <\/div>\n              <div class=\"year\">\n                  <b>Year: <\/b>\n                  <select data-yourir=\"year\" name=\"year\" class=\"select-year\">\n                      <option value=\"none\">All<\/option>\n                      <option value=\"1998\">1998<\/option><option value=\"1999\">1999<\/option><option value=\"2000\">2000<\/option><option value=\"2001\">2001<\/option><option value=\"2002\">2002<\/option><option value=\"2003\">2003<\/option><option value=\"2004\">2004<\/option><option value=\"2005\">2005<\/option><option value=\"2006\">2006<\/option><option value=\"2007\">2007<\/option><option value=\"2008\">2008<\/option><option value=\"2009\">2009<\/option><option value=\"2010\">2010<\/option><option value=\"2011\">2011<\/option><option value=\"2012\">2012<\/option><option value=\"2013\">2013<\/option><option value=\"2014\">2014<\/option><option value=\"2015\">2015<\/option><option value=\"2016\">2016<\/option><option value=\"2017\">2017<\/option><option value=\"2018\">2018<\/option><option value=\"2019\">2019<\/option><option value=\"2020\">2020<\/option><option value=\"2021\">2021<\/option><option value=\"2022\">2022<\/option><option value=\"2023\">2023<\/option><option value=\"2024\">2024<\/option><option value=\"2025\">2025<\/option><option value=\"2026\">2026<\/option>                  <\/select> \n                 <\/div>\n                 <\/div>\n               <!--  <div class=\"page-size\">\n                   <b>Page size <\/b>\n                  <select data-yourir=\"pageSize\" name=\"pageSize\" class=\"select-size\">\n                    <option value=\"10\">10<\/option>\n                    <option value=\"20\">20<\/option>\n                    <option value=\"30\">30<\/option>\n                <\/select> \n                <\/div> -->\n                <\/div>\n               \n                <table data-yourir=\"ifnot isEmpty\" style=\"display: table;\" class=\"mobile\">\n                    <tbody data-yourir=\"items\">\n                      \n                      <tr data-yourir-id=\"ntu.asx\/6A887316\">\n                      \n\n                      <td>\n                      <div data-yourir=\"$cur.heading\" class=\"yourir-announcement-heading row1\">\n                        \n                      <\/div>\n                      <div data-yourir=\"$cur.date format='D MMM, YYYY'\" class=\"date row3\">\n                        \n                      <\/div>\n                        <\/td>\n                         <td data-yourir=\"$cur.priceSensitive\" class=\"yourir-price-sensitive row2\"><span class=\"yourir-tooltip-wrapper\"><span class=\"yourir-price-sensitive\"><\/span><span class=\"sen\">Price Sensitive<\/span><\/span><\/td>\n                        \n                    <\/tr><\/tbody>\n                <\/table>\n                <div class=\"nav\" data-yourir=\"ifnot isEmpty\" style=\"display: block;text-align: center;\">\n                    <div style=\"margin-top: 30px\" class=\"stock-pagination\"> \n                        <button class=\"prevPage\" data-yourir=\"prevPage\" disabled=\"\">\u276c<\/button> \n                        <button data-yourir=\"navPage1\" class=\"yourir-active naviga\"><\/button> \n                        <button data-yourir=\"navPage2\" class=\"naviga\"><\/button> \n                        <button data-yourir=\"navPage3\" class=\"naviga\"><\/button> \n                        <button data-yourir=\"navPage4\" class=\"naviga\"><\/button> \n                        <button class=\"nextPage\" data-yourir=\"nextPage\">\u276d<\/button>\n                    <\/div>\n                <\/div>\n                <div data-yourir=\"if isEmpty\" style=\"display: none;\">\n                    No results\n                <\/div>\n        <\/div>\n        \n<\/div><\/section>\n\n\n\n<section id=\"company-presentation\" class=\"wp-block-gutentor-m3 alignwide section-gme074766 gutentor-module gutentor-container-cover has-color-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gm02e108f\" class=\"wp-block-gutentor-m4 section-gm02e108f gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm148d53\" class=\"wp-block-gutentor-m4-col col-gm148d53 gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm148d53\" class=\"section-gm148d53 gutentor-col-wrap\">\n<h3 class=\"wp-block-heading\">About Prescient Therapeutics<\/h3>\n\n\n\n<p>Prescient Therapeutics develops personalised therapies to conquer cancer. It has a broad portfolio of well advanced assets developed with world-leading partners including Yale, UPenn, Oxford, Moffitt &amp; Peter MacCallum.<\/p>\n\n\n\n<p>Prescient&#8217;s&nbsp;first&nbsp;in class targeted therapy &#8211; PTX-100 &#8211; is currently in clinical development and showing encouraging activity&nbsp;in diseases of unmet need.<\/p>\n\n\n\n<p>Prescient also owns the exclusive rights to two next generation cell therapy platform technologies, OmniCAR and CellPryme \u2013 both with the potential to enhance cell therapies and overcome challenges faced by current generation approaches \u2013 effectively giving Prescient a \u2018shovels to the gold rush\u2019 advantage in this burgeoning area of cancer treatment.<\/p>\n\n\n\n<div class=\"here-text\" style=\"display:none;\"><p>Watch the latest investor briefing <a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/821144927\">here<\/a> or Watch the Fireside discussion and Q&amp;A recording <a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/882325416\">here<\/a>.<\/p><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm4072817\" class=\"wp-block-gutentor-m4 alignwide section-gm4072817 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm2beaab\" class=\"wp-block-gutentor-m4-col col-gm2beaab gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-left\"><div id=\"section-gm2beaab\" class=\"section-gm2beaab gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/03\/PTX-QA-3.png\"\/><a class=\"click-zoom\" href=\"https:\/\/vimeo.com\/1103329295?share=copy\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Investor Briefing<\/strong><\/strong><\/h4>\n\n\n\n<p>37 mins | 22 July, 2025<a href=\"https:\/\/player.vimeo.com\/video\/1070908494\"><\/a><\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/vimeo.com\/1103329295?share=copy\" data-target=\"latest-investor-briefing\">Watch Video<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmbd8b96\" class=\"wp-block-gutentor-m4-col col-gmbd8b96 gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-right\"><div id=\"section-gmbd8b96\" class=\"section-gmbd8b96 gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2023\/12\/PTX-investor-presentation-deck-thumbnails-3.png\"\/><a class=\"click-zoom\" href=\"https:\/\/reachmarkets.com.au\/wp-content\/themes\/neori\/inc\/pdfjs\/web\/viewer.html?file=https:\/\/7664250.fs1.hubspotusercontent-ap1.net\/hubfs\/7664250\/PTX%20Presentation_May2025_New%20updates_FINAL%20PTX%20RM_DigiVer.pdf\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Investor Presentation<\/strong><\/strong><\/h4>\n\n\n\n<p>35 pages | July 2025<\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/reachmarkets.com.au\/wp-content\/themes\/neori\/inc\/pdfjs\/web\/viewer.html?file=https:\/\/7664250.fs1.hubspotusercontent-ap1.net\/hubfs\/7664250\/PTX%20Presentation_May2025_New%20updates_FINAL%20PTX%20RM_DigiVer.pdf\">Read PDF<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm474fd87\" class=\"wp-block-gutentor-m4 alignwide section-gm474fd87 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm58b51c\" class=\"wp-block-gutentor-m4-col col-gm58b51c gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-left\"><div id=\"section-gm58b51c\" class=\"section-gm58b51c gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/PTX-Miles-Prince.png\"\/><a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/1030943340\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong><strong>Q&amp;A with Miles Prince<\/strong><\/strong><\/strong><\/h4>\n\n\n\n<p>13 mins | December 2024<a href=\"https:\/\/player.vimeo.com\/video\/1030943340\"><\/a><\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/player.vimeo.com\/video\/1030943340\" data-target=\"latest-investor-briefing\">Watch Video<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmbb6c7a\" class=\"wp-block-gutentor-m4-col col-gmbb6c7a gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-left\"><div id=\"section-gmbb6c7a\" class=\"section-gmbb6c7a gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/PTX-James-Campbell-2.png\"\/><a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/1074488944\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Q&amp;A with Dr James Campbell<\/strong><\/strong><\/h4>\n\n\n\n<p>8 mins | April 2025<\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/player.vimeo.com\/video\/1074488944\" data-target=\"latest-investor-briefing\">Watch Video<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gmbacd216\" class=\"wp-block-gutentor-m4 alignwide section-gmbacd216 gutentor-module gutentor-advanced-columns d-none\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm43ffc5\" class=\"wp-block-gutentor-m4-col col-gm43ffc5 gutentor-single-column  grid-lg-4 grid-md-12 grid-12 cp-left\"><div id=\"section-gm43ffc5\" class=\"section-gm43ffc5 gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/03\/PTX-QA-3.png\"\/><a class=\"click-zoom\" href=\"https:\/\/vimeo.com\/1070908494?share=copy\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Investor Briefing<\/strong><\/strong><\/h4>\n\n\n\n<p>41 mins | March 2025<\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/player.vimeo.com\/video\/1070908494\" data-target=\"latest-investor-briefing\">Watch Video<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n\n\n\n<p><a href=\"https:\/\/wp-media.reachmarkets.com.au\/wp-content\/uploads\/2024\/03\/12105044\/PrescientTherapeuticsupdatereport7March2024.pdf\"><\/a><\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmb3bc11\" class=\"wp-block-gutentor-m4-col col-gmb3bc11 gutentor-single-column  grid-lg-4 grid-md-12 grid-12 cp-right\"><div id=\"section-gmb3bc11\" class=\"section-gmb3bc11 gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2023\/12\/PTX-investor-presentation-deck-thumbnails-3.png\"\/><a class=\"click-zoom\" href=\"https:\/\/7664250.fs1.hubspotusercontent-na1.net\/hubfs\/7664250\/PTX%20Presentation%20Mar%20%202025%20Final%2030%20March%202025%20.pdf\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Investor Presentation<\/strong><\/strong><\/h4>\n\n\n\n<p>28 pages | March 2025<a href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/04\/PTX-Presentation-April-2024.pdf\"><\/a><\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/7664250.fs1.hubspotusercontent-na1.net\/hubfs\/7664250\/PTX%20Presentation%20Mar%20%202025%20Final%2030%20March%202025%20%20-%20Digital%20ver..pdf\" data-target=\"latest-investor-briefing\">Read PDF<\/a><script>jQuery(document).ready(function($) {\n$( window ).load(function() {\n\tvar url = location.hash;\n\tconsole.log('get', url);\n\t$('.click-zoom').each(function(){\n\t\tvar eEctive = $(this).attr('data-target');\n\t\tvar active = \"#\"+eEctive;\n\t\tconsole.log('active', active);\n\t\tif(url == active)\n\t\t{\n\t\t\tconsole.log('test');\n\t\t\t$(this).click();\n\t\t}\n\t})\n});\n});<\/script>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm7415da\" class=\"wp-block-gutentor-m4-col col-gm7415da gutentor-single-column  grid-lg-4 grid-md-12 grid-12 cp-left\"><div id=\"section-gm7415da\" class=\"section-gm7415da gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-Miles-Prince.png\"\/><a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/1030943340\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><strong>Q&amp;A with Miles Prince<\/strong><\/strong><\/h4>\n\n\n\n<p>13 mins | December 2024<\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/player.vimeo.com\/video\/1030943340\" data-target=\"latest-investor-briefing\">Watch Video<\/a><script>jQuery(document).ready(function($) {\r\n$( window ).load(function() {\r\n\tvar url = location.hash;\r\n\tconsole.log('get', url);\r\n\t$('.click-zoom').each(function(){\r\n\t\tvar eEctive = $(this).attr('data-target');\r\n\t\tvar active = \"#\"+eEctive;\r\n\t\tconsole.log('active', active);\r\n\t\tif(url == active)\r\n\t\t{\r\n\t\t\tconsole.log('test');\r\n\t\t\t$(this).click();\r\n\t\t}\r\n\t})\r\n});\r\n});<\/script>\n\n\n\n<p><a href=\"https:\/\/player.vimeo.com\/video\/742137536\"><\/a><\/p>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm0d46280\" class=\"wp-block-gutentor-m3 section-gm0d46280 gutentor-module gutentor-container-cover d-none\"><div class=\"grid-container\">\n<iframe loading=\"lazy\" class=\"pdfjs-viewer\" width=\"100%\" height=\"500\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/themes\/enouvo\/inc\/pdfjs\/web\/viewer.html?file=https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2021\/10\/RD-Presentation-Sep-21.pdf#zoom=page-fit\"><\/iframe>\n<\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"company-presentation\" class=\"wp-block-gutentor-m3 alignwide section-gm51732aa gutentor-module gutentor-container-cover has-color-bg has-custom-bg d-none\"><div class=\"grid-container\">\n<section id=\"gm196bc89\" class=\"wp-block-gutentor-m4 alignwide section-gm196bc89 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm91c474\" class=\"wp-block-gutentor-m4-col col-gm91c474 gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm91c474\" class=\"section-gm91c474 gutentor-col-wrap\">\n<section id=\"gm255886f\" class=\"wp-block-gutentor-m4 alignwide section-gm255886f gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm19b93c\" class=\"wp-block-gutentor-m4-col col-gm19b93c gutentor-single-column  grid-lg-5 grid-md-12 grid-12\"><div id=\"section-gm19b93c\" class=\"section-gm19b93c gutentor-col-wrap\">\n<div class=\"date-top\">8th April, 2022<\/div>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmd4b9b8\" class=\"wp-block-gutentor-m4-col col-gmd4b9b8 gutentor-single-column  grid-lg-7 grid-md-12 grid-12\"><div id=\"section-gmd4b9b8\" class=\"section-gmd4b9b8 gutentor-col-wrap\">\n<p>Watch this 5-minute video to hear from CEO Michael Davidson to learn more about:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>How Prescienttherapeutics has accelerated its growth through partnerships with industry leaders Square, Stripe and Zip<\/li>\n\n\n\n<li>How the company\u2019s pure tech approach and first-mover advantage is disrupting the SME finance market with more than 1.25 million potential customers<\/li>\n\n\n\n<li>How the company organically grew 420% since March 2021, hitting 30% quarter-on-quarter growth in March 2022, and its plans to continue growing exponentially<\/li>\n<\/ul>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm872fcb1\" class=\"wp-block-gutentor-m3 section-gm872fcb1 gutentor-module gutentor-container-cover d-none\"><div class=\"grid-container\">\n<iframe loading=\"lazy\" class=\"pdfjs-viewer\" width=\"100%\" height=\"500\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/themes\/enouvo\/inc\/pdfjs\/web\/viewer.html?file=https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2021\/10\/RD-Presentation-Sep-21.pdf#zoom=page-fit\"><\/iframe>\n<\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"gmf2f5e85\" class=\"wp-block-gutentor-m3 alignwide section-gmf2f5e85 gutentor-module gutentor-container-cover has-color-bg has-custom-bg d-none\"><div class=\"grid-container\">\n<section id=\"gm68f3ff5\" class=\"wp-block-gutentor-m4 section-gm68f3ff5 gutentor-module gutentor-advanced-columns has-color-bg has-custom-bg stay\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm26e26f\" class=\"wp-block-gutentor-m4-col col-gm26e26f gutentor-single-column  grid-lg-6 grid-md-12 grid-12\"><div id=\"section-gm26e26f\" class=\"section-gm26e26f gutentor-col-wrap\"><\/div><\/div>\n\n\n\n<div id=\"col-gm4cbc92\" class=\"wp-block-gutentor-m4-col col-gm4cbc92 gutentor-single-column  grid-lg-6 grid-md-12 grid-12 mb\"><div id=\"section-gm4cbc92\" class=\"section-gm4cbc92 gutentor-col-wrap\">\n<p class=\"has-white-color has-text-color has-medium-font-size\">To stay up to date with Prescient Therapeutics or to receive alerts on company events, please register your details.<\/p>\n\n\n\n<div id=\"section-gd6c83c\" class=\"wp-block-gutentor-e2 section-gd6c83c gutentor-element gutentor-element-button button-align-left-desktop button-sidebar ticss-e952a764 fw600\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"#\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>Stay up to date<\/span><\/a><\/span><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"share-price\" class=\"wp-block-gutentor-m3 section-gmef0d2b1 gutentor-module gutentor-container-cover has-color-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gmf75e51e\" class=\"wp-block-gutentor-m4 section-gmf75e51e gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm60e70f\" class=\"wp-block-gutentor-m4-col col-gm60e70f gutentor-single-column  grid-lg-12 grid-md-12 grid-12 share-price\"><div id=\"section-gm60e70f\" class=\"section-gm60e70f gutentor-col-wrap\">\n<h3 class=\"wp-block-heading\">Share Price<\/h3>\n\n\n\n<section id=\"gm3fb36a7\" class=\"wp-block-gutentor-m4 section-gm3fb36a7 gutentor-module gutentor-advanced-columns pricepd\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gma3fae9\" class=\"wp-block-gutentor-m4-col col-gma3fae9 gutentor-single-column  grid-lg-2 grid-md-12 grid-12 aligncenter ticss-98d70e5d left0 asx-title\"><div id=\"section-gma3fae9\" class=\"section-gma3fae9 gutentor-col-wrap\">\n<p class=\"has-black-color has-text-color\">Prescient Therapeutics<\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm173664\" class=\"wp-block-gutentor-m4-col col-gm173664 gutentor-single-column  grid-lg-10 grid-md-12 grid-12\"><div id=\"section-gm173664\" class=\"section-gm173664 gutentor-col-wrap\">        <div class=\"product-carousel text-center white-color\" data-slick='{\"slidesToShow\":\"6\",\"slidesToScroll\":1,\"arrows\":false,\"dots\":false,\"fade\":false,\"autoplay\":false,\"speed\":1000,\"responsive\":[{\"breakpoint\":991,\"settings\":{\"slidesToShow\":10,\"arrows\":false}},{\"breakpoint\":767,\"settings\":{\"slidesToShow\":10,\"arrows\":false}}]}'>\n            <div class=\"product title\">\n                <div class=\"product-bottom \">\n                <p class=\"product-prices\">\n                    <span  class=\"price-investor\">PTX<\/span><br\/>\n                    <span class=\"title-investor\">ASX code<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom \">\n                <p class=\"product-prices\">\n                    <span data-yourir=\"price\" class=\"price-investor\"><\/span><br\/>\n                    <span class=\"title-investor\">Current price<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                    \n                    <span class=\"price-investor\" data-yourir=\"prevClose\"><\/span><br\/>\n                    <span class=\"title-investor\">Previous Close<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                   \n                    <span class=\"price-investor\" data-yourir=\"pctChange\"><\/span><br\/>\n                     <span class=\"title-investor\">Movement<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n               \n                <span class=\"price-investor\" data-yourir=\"volume\"><\/span><br\/>\n                 <span class=\"title-investor\">Volume<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <div class=\"product\">\n                <div class=\"product-bottom\">\n                <p class=\"product-prices\">\n                   \n                    <span class=\"price-investor\" data-yourir=\"marketCap scale=true\"><\/span><br\/>\n                     <span class=\"title-investor\">Market Cap<\/span>\n\n                <\/p>\n                <\/div>\n            <\/div>\n            <\/div>\n        \n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n        <script src=\"https:\/\/yourir.info\/3dd816e0350bdd55.js\"><\/script>\n        <script>\n            \/\/ var jExample = jQuery.noConflict();\n            var abc = window.setInterval(function(){\n                if( \/Android|webOS|iPhone|iPad|iPod|BlackBerry|IEMobile|Opera Mini\/i.test(navigator.userAgent) ) {\n                    document.querySelectorAll(\".yourir-chart-xaxis-outside\").forEach(a=>a.style.display = \"none\");\n                }\n            }, 100);\n        <\/script>\n        <section class=\"round-border1\">\n            \n            <div id=\"collapse3\" style=\"min-height: 100px;\">\n                <div class=\"container-fluid container-fluid-shareprice\" id=\"shareprice\">\n                    <div class=\"container container-investor\">\n                        <div class=\"row\" style=\" margin-left: 0; \">\n                            <div class=\"col-sm-12\" style=\"padding: 0px;\">\n                                <div class=\"chart-left col-sm-12\">\n                                    <section class=\"document\" style=\"padding-left:10px;\">\n                                        <div data-yourir=\"priceComparisonChart1 range=3m ismobile=true volume.visible=true news.visible=true announcements.visible=true\">\n                                            <div class=\"price-chart yourir-chart-xaxis-labels-centered-with-tick\" data-yourir=\"plots\">  \n                                            <\/div>\n                                            <div class=\"button-style\" style=\"margin-top: 40px;\">\n                                                <strong>Range<\/strong>\n                                                <button data-yourir=\"range\" value=\"1d\" class=\"range first\">Today<\/button>\n                                                <button data-yourir=\"range\" value=\"5d\" class=\"range \">5 Days<\/button>\n                                                <button data-yourir=\"range\" value=\"1m\" class=\"range\">1 Month<\/button>\n                                                <button data-yourir=\"range\" value=\"3m\" class=\"range\">3 Months<\/button>\n                                                <button data-yourir=\"range\" value=\"6m\" class=\"range\">6 Months<\/button>\n                                                <button data-yourir=\"range\" value=\"ytd\" class=\"range\">YTD<\/button>\n                                                <button data-yourir=\"range\" value=\"1y\" class=\"range\">1 Year<\/button>\n                                                <button data-yourir=\"range\" value=\"2y\" class=\"range\">2 Years<\/button>\n                                                <button data-yourir=\"range\" value=\"5y\" class=\"range\">5 Years<\/button>\n                                                <button data-yourir=\"range\" value=\"99y\" class=\"range last\">max<\/button>\n                                            <\/div>\n                                            <div class=\"button-style\" style=\"margin-top: 20px;\"><strong>Show<\/strong>\n                                                <button data-yourir=\"volume.visible\" class=\"volume first\">Volume<\/button>\n                                                <button data-yourir=\"announcements.visible\" id=\"annou-news\" class=\"news click last \">News<\/button>\n                                            <\/div>\n                                           \n                                        <\/div>\n                                    <\/section>\n                                <\/div>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            \n        <\/section>\n        \n        \n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"announcements\" class=\"wp-block-gutentor-m3 section-gm8a8dc31 gutentor-module gutentor-container-cover\"><div class=\"grid-container\">\n<section id=\"gm61a0387\" class=\"wp-block-gutentor-m4 section-gm61a0387 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm2c633f\" class=\"wp-block-gutentor-m4-col col-gm2c633f gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm2c633f\" class=\"section-gm2c633f gutentor-col-wrap\">\n<h3 class=\"wp-block-heading\">Latest announcements<\/h3>\n\n\n\n<section id=\"section-a8d30b9a-3d95-4e27-a066-d2cbb5b6f8c8\" class=\"wp-block-gutentor-tabs gutentor-section gutentor-tabs-wrapper tabs-template1 tab-horizontal\"><div class=\"grid-container\"><div class=\"gutentor-tabs-container gutentor-grid-item-wrap\"><div class=\"gutentor-tabs tablist-center\"><span class=\"gutentor-tabs-list gutentor-single-item-0 gutentor-tab-active\" data-index=\"gutentor-single-item-0\"><div class=\"gutentor-single-item-tabs gutentor-single-item\">Recent announcements<\/div><\/span><span class=\"gutentor-tabs-list gutentor-single-item-1\" data-index=\"gutentor-single-item-1\"><div class=\"gutentor-single-item-tabs gutentor-single-item\">Periodic reports<\/div><\/span><span class=\"gutentor-tabs-list gutentor-single-item-2\" data-index=\"gutentor-single-item-2\"><div class=\"gutentor-single-item-tabs gutentor-single-item\">Annual reports<\/div><\/span><\/div><div class=\"gutentor-tabs-content-wrap text-left\"><div class=\"gutentor-single-item gutentor-tabs-content gutentor-single-item-0 gutentor-tab-content-active\"><div class=\"gutentor-single-item-tabs gutentor-single-item\"><div class=\"gutentor-single-item-content\">        <div class=\"container-announcements\" data-yourir=\"announcements filter=priceSensitive pageSize=3\">\n            <div class=\"row-anou\">\n                <div data-yourir=\"items\" class=\"grid-row\">\n                    <div class=\"grid-sm-4 column4-announ\">\n                        <div class=\"container-announ\">\n                            <div class=\"box-announ\"><span data-yourir=\"$cur.heading\" class=\"title-announ yourir-announcement-heading\"><\/span><\/div>\n                            <div class=\"content-announ\"><span data-yourir=\"$cur.date format='D MMM, YYYY'\" class=\"data-date\"><\/span><\/div>\n                            <div class=\"link-announ\">\n                                <span class=\"yourir-download\">\n                                    <a class=\"sh-button sh-button-xsmall sh-button-icon-left\" href=\"#\" target=\"_self\">\n                                            <svg\n                                              xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                                              x=\"0\"\n                                              y=\"0\"\n                                              enableBackground=\"new 0 0 58 58\"\n                                              version=\"1.1\"\n                                              viewBox=\"0 0 58 58\"\n                                              xmlSpace=\"preserve\"\n                                            >\n                                              <path d=\"M50.95 12.187l-.771-.771L40.084 1.321 39.313.55A1.891 1.891 0 0037.985 0H8.963C7.777 0 6.5.916 6.5 2.926V56c0 .837.842 1.653 1.838 1.91.05.013.098.032.15.042.156.031.315.048.475.048h40.074c.16 0 .319-.017.475-.048.052-.01.1-.029.15-.042.996-.257 1.838-1.073 1.838-1.91V13.978c0-.767-.092-1.333-.55-1.791zM47.935 12H39.5V3.565L47.935 12zM8.963 56c-.071 0-.135-.026-.198-.049a.458.458 0 01-.265-.414V41h41v14.537a.46.46 0 01-.265.414c-.063.023-.127.049-.198.049H8.963zM8.5 39V2.926c0-.217.033-.926.463-.926h28.595a1.54 1.54 0 00-.058.391V14h11.609c.135 0 .264-.025.39-.058l.001.036V39h-41z\"><\/path>\n                                              <path d=\"M22.042 44.744a3.438 3.438 0 00-1.128-.615 4.067 4.067 0 00-1.271-.205h-2.898V54h1.641v-3.637h1.217c.528 0 1.012-.077 1.449-.232s.811-.374 1.121-.656c.31-.282.551-.631.725-1.046.173-.415.26-.877.26-1.388 0-.483-.103-.918-.308-1.306s-.475-.717-.808-.991zm-.622 3.329c-.101.278-.232.494-.396.649a1.499 1.499 0 01-.54.335 1.808 1.808 0 01-.595.103h-1.504v-3.992h1.23c.419 0 .756.066 1.012.198.255.132.453.296.595.492.141.196.234.401.28.615a2.8 2.8 0 01.068.567c0 .411-.05.755-.15 1.033zM31.954 45.4c-.424-.446-.957-.805-1.6-1.073s-1.388-.403-2.235-.403h-3.035V54h3.814c.127 0 .323-.016.588-.048.264-.032.556-.104.875-.219.319-.114.649-.285.991-.513s.649-.54.923-.937.499-.889.677-1.477.267-1.297.267-2.126a5.06 5.06 0 00-.314-1.757 4.436 4.436 0 00-.951-1.523zm-1.196 6.33c-.492.711-1.294 1.066-2.406 1.066h-1.627v-7.629h.957c.784 0 1.422.103 1.914.308s.882.474 1.169.807.48.704.581 1.114c.1.41.15.825.15 1.244 0 1.349-.246 2.38-.738 3.09z\"><\/path>\n                                              <path d=\"M35.598 54L37.266 54 37.266 49.461 41.477 49.461 41.477 48.34 37.266 48.34 37.266 45.168 41.9 45.168 41.9 43.924 35.598 43.924z\"><\/path>\n                                              <path d=\"M38.428 22.961c-.919 0-2.047.12-3.358.358-1.83-1.942-3.74-4.778-5.088-7.562 1.337-5.629.668-6.426.373-6.802-.314-.4-.757-1.049-1.261-1.049-.211 0-.787.096-1.016.172-.576.192-.886.636-1.134 1.215-.707 1.653.263 4.471 1.261 6.643-.853 3.393-2.284 7.454-3.788 10.75-3.79 1.736-5.803 3.441-5.985 5.068-.066.592.074 1.461 1.115 2.242.285.213.619.326.967.326.875 0 1.759-.67 2.782-2.107.746-1.048 1.547-2.477 2.383-4.251 2.678-1.171 5.991-2.229 8.828-2.822 1.58 1.517 2.995 2.285 4.211 2.285.896 0 1.664-.412 2.22-1.191.579-.811.711-1.537.39-2.16-.385-.749-1.334-1.115-2.9-1.115zm-17.892 9.673c-.468-.359-.441-.601-.431-.692.062-.556.933-1.543 3.07-2.744-1.62 2.992-2.49 3.389-2.639 3.436zm8.2-22.922c.043-.014 1.045 1.101.096 3.216-1.426-1.459-.194-3.183-.096-3.216zm-2.067 16.026a71.291 71.291 0 002.674-7.564c1.123 2.018 2.472 3.976 3.822 5.544a49.812 49.812 0 00-6.496 2.02zm12.901-.479c-.308.431-.976.441-1.21.441-.533 0-.732-.317-1.547-.944a14.395 14.395 0 011.811-.108c.889 0 1.052.131 1.175.197-.022.071-.08.205-.229.414z\"><\/path>\n                                            <\/svg>\n                                        <span class=\"sh-button-text pdflink-text\"> Download file PDF<\/span>\n                                    <\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <\/div><\/div><\/div><div class=\"gutentor-single-item gutentor-tabs-content gutentor-single-item-1\"><div class=\"gutentor-single-item-tabs gutentor-single-item\"><div class=\"gutentor-single-item-content\">        <div class=\"container-announcements\" data-yourir=\"announcements filter=periodicReports pageSize=3\">\n            <div class=\"row-anou\">\n                <div data-yourir=\"items\" class=\"grid-row\">\n                    <div class=\"grid-sm-4 column4-announ\">\n                        <div class=\"container-announ\">\n                            <div class=\"box-announ\"><span data-yourir=\"$cur.heading\" class=\"title-announ yourir-announcement-heading\"><\/span><\/div>\n                            <div class=\"content-announ\"><span data-yourir=\"$cur.date format='D MMM, YYYY'\" class=\"data-date\"><\/span><\/div>\n                            <div class=\"link-announ\">\n                                <span class=\"yourir-download\">\n                                    <a class=\"sh-button sh-button-xsmall sh-button-icon-left\" href=\"#\" target=\"_self\">\n                                            <svg\n                                              xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                                              x=\"0\"\n                                              y=\"0\"\n                                              enableBackground=\"new 0 0 58 58\"\n                                              version=\"1.1\"\n                                              viewBox=\"0 0 58 58\"\n                                              xmlSpace=\"preserve\"\n                                            >\n                                              <path d=\"M50.95 12.187l-.771-.771L40.084 1.321 39.313.55A1.891 1.891 0 0037.985 0H8.963C7.777 0 6.5.916 6.5 2.926V56c0 .837.842 1.653 1.838 1.91.05.013.098.032.15.042.156.031.315.048.475.048h40.074c.16 0 .319-.017.475-.048.052-.01.1-.029.15-.042.996-.257 1.838-1.073 1.838-1.91V13.978c0-.767-.092-1.333-.55-1.791zM47.935 12H39.5V3.565L47.935 12zM8.963 56c-.071 0-.135-.026-.198-.049a.458.458 0 01-.265-.414V41h41v14.537a.46.46 0 01-.265.414c-.063.023-.127.049-.198.049H8.963zM8.5 39V2.926c0-.217.033-.926.463-.926h28.595a1.54 1.54 0 00-.058.391V14h11.609c.135 0 .264-.025.39-.058l.001.036V39h-41z\"><\/path>\n                                              <path d=\"M22.042 44.744a3.438 3.438 0 00-1.128-.615 4.067 4.067 0 00-1.271-.205h-2.898V54h1.641v-3.637h1.217c.528 0 1.012-.077 1.449-.232s.811-.374 1.121-.656c.31-.282.551-.631.725-1.046.173-.415.26-.877.26-1.388 0-.483-.103-.918-.308-1.306s-.475-.717-.808-.991zm-.622 3.329c-.101.278-.232.494-.396.649a1.499 1.499 0 01-.54.335 1.808 1.808 0 01-.595.103h-1.504v-3.992h1.23c.419 0 .756.066 1.012.198.255.132.453.296.595.492.141.196.234.401.28.615a2.8 2.8 0 01.068.567c0 .411-.05.755-.15 1.033zM31.954 45.4c-.424-.446-.957-.805-1.6-1.073s-1.388-.403-2.235-.403h-3.035V54h3.814c.127 0 .323-.016.588-.048.264-.032.556-.104.875-.219.319-.114.649-.285.991-.513s.649-.54.923-.937.499-.889.677-1.477.267-1.297.267-2.126a5.06 5.06 0 00-.314-1.757 4.436 4.436 0 00-.951-1.523zm-1.196 6.33c-.492.711-1.294 1.066-2.406 1.066h-1.627v-7.629h.957c.784 0 1.422.103 1.914.308s.882.474 1.169.807.48.704.581 1.114c.1.41.15.825.15 1.244 0 1.349-.246 2.38-.738 3.09z\"><\/path>\n                                              <path d=\"M35.598 54L37.266 54 37.266 49.461 41.477 49.461 41.477 48.34 37.266 48.34 37.266 45.168 41.9 45.168 41.9 43.924 35.598 43.924z\"><\/path>\n                                              <path d=\"M38.428 22.961c-.919 0-2.047.12-3.358.358-1.83-1.942-3.74-4.778-5.088-7.562 1.337-5.629.668-6.426.373-6.802-.314-.4-.757-1.049-1.261-1.049-.211 0-.787.096-1.016.172-.576.192-.886.636-1.134 1.215-.707 1.653.263 4.471 1.261 6.643-.853 3.393-2.284 7.454-3.788 10.75-3.79 1.736-5.803 3.441-5.985 5.068-.066.592.074 1.461 1.115 2.242.285.213.619.326.967.326.875 0 1.759-.67 2.782-2.107.746-1.048 1.547-2.477 2.383-4.251 2.678-1.171 5.991-2.229 8.828-2.822 1.58 1.517 2.995 2.285 4.211 2.285.896 0 1.664-.412 2.22-1.191.579-.811.711-1.537.39-2.16-.385-.749-1.334-1.115-2.9-1.115zm-17.892 9.673c-.468-.359-.441-.601-.431-.692.062-.556.933-1.543 3.07-2.744-1.62 2.992-2.49 3.389-2.639 3.436zm8.2-22.922c.043-.014 1.045 1.101.096 3.216-1.426-1.459-.194-3.183-.096-3.216zm-2.067 16.026a71.291 71.291 0 002.674-7.564c1.123 2.018 2.472 3.976 3.822 5.544a49.812 49.812 0 00-6.496 2.02zm12.901-.479c-.308.431-.976.441-1.21.441-.533 0-.732-.317-1.547-.944a14.395 14.395 0 011.811-.108c.889 0 1.052.131 1.175.197-.022.071-.08.205-.229.414z\"><\/path>\n                                            <\/svg>\n                                        <span class=\"sh-button-text pdflink-text\"> Download file PDF<\/span>\n                                    <\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <\/div><\/div><\/div><div class=\"gutentor-single-item gutentor-tabs-content gutentor-single-item-2\"><div class=\"gutentor-single-item-tabs gutentor-single-item\"><div class=\"gutentor-single-item-content\">        <div class=\"container-announcements\" data-yourir=\"announcements filter=annualReports pageSize=3\">\n            <div class=\"row-anou\">\n                <div data-yourir=\"items\" class=\"grid-row\">\n                    <div class=\"grid-sm-4 column4-announ\">\n                        <div class=\"container-announ\">\n                            <div class=\"box-announ\"><span data-yourir=\"$cur.heading\" class=\"title-announ yourir-announcement-heading\"><\/span><\/div>\n                            <div class=\"content-announ\"><span data-yourir=\"$cur.date format='D MMM, YYYY'\" class=\"data-date\"><\/span><\/div>\n                            <div class=\"link-announ\">\n                                <span class=\"yourir-download\">\n                                    <a class=\"sh-button sh-button-xsmall sh-button-icon-left\" href=\"#\" target=\"_self\">\n                                            <svg\n                                              xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                                              x=\"0\"\n                                              y=\"0\"\n                                              enableBackground=\"new 0 0 58 58\"\n                                              version=\"1.1\"\n                                              viewBox=\"0 0 58 58\"\n                                              xmlSpace=\"preserve\"\n                                            >\n                                              <path d=\"M50.95 12.187l-.771-.771L40.084 1.321 39.313.55A1.891 1.891 0 0037.985 0H8.963C7.777 0 6.5.916 6.5 2.926V56c0 .837.842 1.653 1.838 1.91.05.013.098.032.15.042.156.031.315.048.475.048h40.074c.16 0 .319-.017.475-.048.052-.01.1-.029.15-.042.996-.257 1.838-1.073 1.838-1.91V13.978c0-.767-.092-1.333-.55-1.791zM47.935 12H39.5V3.565L47.935 12zM8.963 56c-.071 0-.135-.026-.198-.049a.458.458 0 01-.265-.414V41h41v14.537a.46.46 0 01-.265.414c-.063.023-.127.049-.198.049H8.963zM8.5 39V2.926c0-.217.033-.926.463-.926h28.595a1.54 1.54 0 00-.058.391V14h11.609c.135 0 .264-.025.39-.058l.001.036V39h-41z\"><\/path>\n                                              <path d=\"M22.042 44.744a3.438 3.438 0 00-1.128-.615 4.067 4.067 0 00-1.271-.205h-2.898V54h1.641v-3.637h1.217c.528 0 1.012-.077 1.449-.232s.811-.374 1.121-.656c.31-.282.551-.631.725-1.046.173-.415.26-.877.26-1.388 0-.483-.103-.918-.308-1.306s-.475-.717-.808-.991zm-.622 3.329c-.101.278-.232.494-.396.649a1.499 1.499 0 01-.54.335 1.808 1.808 0 01-.595.103h-1.504v-3.992h1.23c.419 0 .756.066 1.012.198.255.132.453.296.595.492.141.196.234.401.28.615a2.8 2.8 0 01.068.567c0 .411-.05.755-.15 1.033zM31.954 45.4c-.424-.446-.957-.805-1.6-1.073s-1.388-.403-2.235-.403h-3.035V54h3.814c.127 0 .323-.016.588-.048.264-.032.556-.104.875-.219.319-.114.649-.285.991-.513s.649-.54.923-.937.499-.889.677-1.477.267-1.297.267-2.126a5.06 5.06 0 00-.314-1.757 4.436 4.436 0 00-.951-1.523zm-1.196 6.33c-.492.711-1.294 1.066-2.406 1.066h-1.627v-7.629h.957c.784 0 1.422.103 1.914.308s.882.474 1.169.807.48.704.581 1.114c.1.41.15.825.15 1.244 0 1.349-.246 2.38-.738 3.09z\"><\/path>\n                                              <path d=\"M35.598 54L37.266 54 37.266 49.461 41.477 49.461 41.477 48.34 37.266 48.34 37.266 45.168 41.9 45.168 41.9 43.924 35.598 43.924z\"><\/path>\n                                              <path d=\"M38.428 22.961c-.919 0-2.047.12-3.358.358-1.83-1.942-3.74-4.778-5.088-7.562 1.337-5.629.668-6.426.373-6.802-.314-.4-.757-1.049-1.261-1.049-.211 0-.787.096-1.016.172-.576.192-.886.636-1.134 1.215-.707 1.653.263 4.471 1.261 6.643-.853 3.393-2.284 7.454-3.788 10.75-3.79 1.736-5.803 3.441-5.985 5.068-.066.592.074 1.461 1.115 2.242.285.213.619.326.967.326.875 0 1.759-.67 2.782-2.107.746-1.048 1.547-2.477 2.383-4.251 2.678-1.171 5.991-2.229 8.828-2.822 1.58 1.517 2.995 2.285 4.211 2.285.896 0 1.664-.412 2.22-1.191.579-.811.711-1.537.39-2.16-.385-.749-1.334-1.115-2.9-1.115zm-17.892 9.673c-.468-.359-.441-.601-.431-.692.062-.556.933-1.543 3.07-2.744-1.62 2.992-2.49 3.389-2.639 3.436zm8.2-22.922c.043-.014 1.045 1.101.096 3.216-1.426-1.459-.194-3.183-.096-3.216zm-2.067 16.026a71.291 71.291 0 002.674-7.564c1.123 2.018 2.472 3.976 3.822 5.544a49.812 49.812 0 00-6.496 2.02zm12.901-.479c-.308.431-.976.441-1.21.441-.533 0-.732-.317-1.547-.944a14.395 14.395 0 011.811-.108c.889 0 1.052.131 1.175.197-.022.071-.08.205-.229.414z\"><\/path>\n                                            <\/svg>\n                                        <span class=\"sh-button-text pdflink-text\"> Download file PDF<\/span>\n                                    <\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<div id=\"section-g5f3e4e\" class=\"wp-block-gutentor-e2 section-g5f3e4e gutentor-element gutentor-element-button button-align-left-desktop boxshadow button-ennou\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/share-price-and-announcements\/\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>See all announcements<\/span><\/a><\/span><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"team\" class=\"wp-block-gutentor-m3 section-gmda651a8 gutentor-module gutentor-container-cover has-color-bg has-custom-bg d-none team\"><div class=\"grid-container\">\n<h2 class=\"wp-block-heading\">Our board<\/h2>\n\n\n\n<section id=\"section-7dbe3205-26e8-4cfe-abae-a9dc96c08696\" class=\"wp-block-gutentor-tabs gutentor-section gutentor-tabs-wrapper tabs-template1 tab-horizontal custom-tab\"><div class=\"grid-container\"><div class=\"gutentor-tabs-container gutentor-grid-item-wrap\"><div class=\"gutentor-tabs tablist-left\"><span class=\"gutentor-tabs-list gutentor-single-item-0 gutentor-tab-active\" data-index=\"gutentor-single-item-0\"><div class=\"gutentor-single-item-tabs gutentor-single-item\">Board<\/div><\/span><span class=\"gutentor-tabs-list gutentor-single-item-1\" data-index=\"gutentor-single-item-1\"><div class=\"gutentor-single-item-tabs gutentor-single-item\">Management<\/div><\/span><\/div><div class=\"gutentor-tabs-content-wrap text-left\"><div class=\"gutentor-single-item gutentor-tabs-content gutentor-single-item-0 gutentor-tab-content-active\"><div class=\"gutentor-single-item-tabs gutentor-single-item\"><div class=\"gutentor-single-item-content\">        <div class=\"team-wrapper col rel\">\n            <div id=\"prev\">\u2039  <\/div>\n            <div class=\"team-list grid-row\">\n                                    <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"212\" idx=\"0\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/10\/James-Campbell-1-500x500-1-150x150.png\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/10\/James-Campbell-1-500x500-1-150x150.png 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/10\/James-Campbell-1-500x500-1-300x300.png 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/10\/James-Campbell-1-500x500-1.png 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Dr James Campbell<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Non-Executive Chairman                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr James Campbell<\/h2>\n                        <h4>Non-Executive Chairman<\/h4>\n                            Dr James Campbell brings to Prescient a solid track record as a scientist and commercial executive. Dr. Campbell has more than 20 years of international biotechnology research, management and leadership experience and has been involved in the creation and\/or transformation of multiple successful Australian and international biotechnology companies.\r\n<br>\r\nHe is currently CEO of Patrys Limited, a company developing novel antibody therapeutics for oncology.\r\n<br>\r\nHe was previously the Chief Financial Officer and Chief Operating Officer of Chemgenex, which was acquired by Cephalon for $230 million in 2011. His responsibilities ranged from IP management to licensing and business development and as a member of the executive team, he helped steer and transform the company from a $10 million research based entity to a company with completed clinical trials and regulatory dossiers submitted to the FDA and EMA before its $230 million sale.\r\n<br>\r\nDr Campbell also has experience advising private biotechnology companies in the US and New Zealand with capital raisings and partnering negotiations.                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"20334\" idx=\"1\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/12\/allen-500x500-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/12\/allen-500x500-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/12\/allen-500x500-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2020\/12\/allen-500x500-1.jpg 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Dr Allen Ebens<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Non-Executive Director                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr Allen Ebens<\/h2>\n                        <h4>Non-Executive Director<\/h4>\n                            <p>Allen Ebens, Ph.D. brings over twenty four years of drug development experience in oncology and hematology, beginning in drug discovery at Exelixis before moving to Genentech where over 11 years he worked from concept to clinic across multiple therapeutic platforms including antibodies, small molecule drugs, antibody-drug conjugates, and T cell recruiting antibodies.<br \/>\nDr. Ebens was recruited from Genentech to establish oncology discovery research at Juno Therapeutics (a CAR-T pioneer), and served as Senior Director, Immune Oncology at NGM Biopharmaceuticals.<br \/>\nHe is currently Chief Scientific Officer of Vera Therapeutics. Dr. Ebens\u2019 scientific contributions include numerous peer-reviewed publications of original research, a significant patent portfolio, and the advancement of nine discovery projects from initial concept to clinical development for multiple targets including one marketed therapeutic. He completed his PhD at UCLA and postdoctoral training at UCSF.<\/p>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"25957\" idx=\"2\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/04\/Ellen-PTX-500x500-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/04\/Ellen-PTX-500x500-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/04\/Ellen-PTX-500x500-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/04\/Ellen-PTX-500x500-1.jpg 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Dr Ellen Feigal<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Non-Executive Director                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr Ellen Feigal<\/h2>\n                        <h4>Non-Executive Director<\/h4>\n                            <p>Dr Feigal is currently a Partner and Head of the Biologics practice at global life sciences advisory firm, NDA Partners LLC, where she leads efforts in designing and executing product development and regulatory strategies in the areas of cell therapies, medical imaging, hematology and oncology. She is also adjunct faculty at the Sandra Day O\u2019Connor College of Law, Arizona State University, where she teaches FDA drug law and medical research ethics and law.<\/p>\n<p>Dr Feigal was formerly Senior Vice President overseeing research and development with the California Institute of Regenerative Medicine, a world-leading research foundation working to accelerate development of new disease modifying treatments and cures for patients with chronic diseases; Executive Medical Director, Global Development at US biotech company Amgen Inc (NASDAQ: AMGN); Vice President of Clinical Sciences at the Translational Genomics Research Institute, and directed the Division of Cancer Treatment and Diagnosis at the National Cancer Institute.<\/p>\n<p>Dr Feigal serves as a Board member for Xencor Inc (NASDAQ: XNCR) a biotechnology company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases. She is also a Director of NextCure (NASDAQ: NXTC) a clinical-stage biotechnology company developing new immunotherapies to treat cancer.<\/p>\n<p>Dr Feigal holds an M.D. from the University of California, Davis School of Medicine. She completed an internal medicine residency at Stanford University and a hematology oncology fellowship at the University of California, San Francisco.<\/p>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"27391\" idx=\"3\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/Dr-Gavin-Shepard-150x150.png\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" \/><p class=\"name text-uppercase fw500\">Dr Gavin Shepherd<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Non-Executive Director                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr Gavin Shepherd<\/h2>\n                        <h4>Non-Executive Director<\/h4>\n                            <p>Dr Shepherd is an accomplished medical professional with 25 years of experience in medicine and a proven track record in driving success in various specialist consulting businesses. After completing his medical qualification at Flinders University, he completed specialist training as a consultant Occupational and Environmental Physician with a fellowship from the Royal Australasian College of Physicians. He graduated dux of his Graduate Diploma in OH+S at Adelaide University and he completed his GAICD qualification in 2011. He is a serial Australian biotech investor and a non-executive director of Lateral Pharma Pty Ltd.<\/p>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"27395\" idx=\"4\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image001-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image001-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image001-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image001.jpg 380w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Melanie Leydin<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Company Secretary                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Melanie Leydin<\/h2>\n                        <h4>Company Secretary<\/h4>\n                            <p>Melanie Leydin is a highly experienced CFO and Company Secretary with 25 years of experience in the accounting profession and 15 years of experience in company secretarial services<\/p>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30618\" idx=\"5\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Mel-BandW-150x150.png\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Mel-BandW-150x150.png 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Mel-BandW-300x300.png 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Mel-BandW.png 595w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Melanie Farris<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Non-Executive Director                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Melanie Farris<\/h2>\n                        <h4>Non-Executive Director<\/h4>\n                            <p>Ms Farris is an experienced non-executive director, governance, risk and communications professional in the listed, public and not-for-profit sectors, possessing a strong track record in the planning, delivery and oversight of strategic corporate, funding, governance and risk projects across industries including life sciences, investment, agriculture, not-for-profit and music industry marketing.<\/p>\n<p>With extensive senior executive tenure including as chief governance and risk officer, chief financial officer, chief operating officer, group company secretary, senior risk and sustainability advisor, prior roles include with Telix Pharmaceuticals Limited (ASX: TLX), Factor Therapeutics Limited (ASX: FTT), Invion Limited (ASX: IVX), Menzies Research Centre, HRH The Prince of Wales\u2019s Office, Global Asset Management, Imperial Cancer Research Fund, and The Prince\u2019s Foundation.<\/p>\n<p>Melanie holds a Bachelor of Communication (Public Relations), and a Graduate Diploma in Applied Corporate Governance. She is a Fellow of the Governance Institute of Australia, a Fellow of the Chartered Governance Institute (UK) and a Graduate of the Australian Institute of Company Directors.<\/p>\n                        <\/div>\n                    <\/div>\n                                    \n            <\/div>\n            <div id=\"next\">\u203a  <\/div>\n            <div class=\"result grid-row\"><\/div>\n        <\/div>\n        <\/div><\/div><\/div><div class=\"gutentor-single-item gutentor-tabs-content gutentor-single-item-1\"><div class=\"gutentor-single-item-tabs gutentor-single-item\"><div class=\"gutentor-single-item-content\">        <div class=\"team-wrapper col rel\">\n            <div id=\"prev\">\u2039  <\/div>\n            <div class=\"team-list grid-row\">\n                                    <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"27397\" idx=\"0\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/img-6-500x500-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/img-6-500x500-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/img-6-500x500-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/img-6-500x500-1.jpg 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Said Sebti, PhD<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Scientific Founder                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Said Sebti, PhD<\/h2>\n                        <h4>Scientific Founder<\/h4>\n                            <ul>\n<li>Co-inventor of PTX-100 &amp; PTX-200<\/li>\n<li><b>Named among top 20 Translational Researchers in the world by Nature Publishing Group<\/b><\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"27399\" idx=\"1\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/image-1.jpg 438w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Terry Chew, M.D.<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Executive Advisor Clinical and Regulatory                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Terry Chew, M.D.<\/h2>\n                        <h4>Executive Advisor Clinical and Regulatory<\/h4>\n                            <ul>\n<li>Hematologist\/oncologist with 20 years experience in biotech &amp; pharma<\/li>\n<li><b>5 New Drug Applications\u00a0<\/b>including DaunoXome, Taxotere and DepoCyte<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30541\" idx=\"2\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Amber-Weissenfluh-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Amber-Weissenfluh-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Amber-Weissenfluh.jpg 169w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Amber Weissenfluh<\/p>                        <p class=\"position text-capitalize fw400\">\n                            CMC Technical Lead                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Amber Weissenfluh<\/h2>\n                        <h4>CMC Technical Lead<\/h4>\n                            <ul>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Highly experienced in reviewing batch records, CMC regulations and documenting CMC information for regulatory submissions<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Expertise in optimising process chemistry<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Formerly Patheon, Alcami, Viking Therapeutics<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">PhD in organic chemistry<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30544\" idx=\"3\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"141\" height=\"141\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Tracey-Owens-PhD.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" \/><p class=\"name text-uppercase fw500\">Tracey Owens PHD<\/p>                        <p class=\"position text-capitalize fw400\">\n                            CMC Project Manager                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Tracey Owens PHD<\/h2>\n                        <h4>CMC Project Manager<\/h4>\n                            <ul>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Experience in project management of drug substance, including synthesis, method development and qualification<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Formerly Sterling Pharma Solutions and Thermo Fisher Scientific<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">PhD in chemical biology<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30546\" idx=\"4\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Luis-Malaver-500x500-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Luis-Malaver-500x500-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Luis-Malaver-500x500-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Luis-Malaver-500x500-1.jpg 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Luis Malaver-Ortega, PhD<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Director Research and Development                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Luis Malaver-Ortega, PhD<\/h2>\n                        <h4>Director Research and Development<\/h4>\n                            <ul>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Over 10 years of experience in biomedical R&amp;D gained through appointments at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), the Australian Institute for Bioengineering and Nanotechnology (AIBN), Me&amp;Biotech, the Melbourne Centre for Nanofabrication (MCN), and The Hudson Institute of Medical Research.<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Technical expertise in cell line development, genome editing, functional genomics, and bioprocessing.<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Co-author and inventor in several scientific articles and patents in biotechnology and cancer research.<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30548\" idx=\"5\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Upaly-Bahadure-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Upaly-Bahadure-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Upaly-Bahadure.jpg 252w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Upaly Bahadure<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Director \u2013 Clinical Affairs & Operations                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Upaly Bahadure<\/h2>\n                        <h4>Director \u2013 Clinical Affairs & Operations<\/h4>\n                            <ul>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Over 17 years of experience in clinical development, driving programs from pre-clinical development through to regulatory submissions and successful commercialisation<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Experience in leading global studies in oncology, including immuno-oncology<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Formerly Beigene Global Clinical Program Lead<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">CRO experience with Chiltern International; Quintiles Research<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Background in Pharmacy and Pharmaceutical Marketing<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30550\" idx=\"6\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Marissa-Lim-Photo-500x500-1-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Marissa-Lim-Photo-500x500-1-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Marissa-Lim-Photo-500x500-1-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Marissa-Lim-Photo-500x500-1.jpg 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">Dr Marissa Lim<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Chief Medical Officer                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr Marissa Lim<\/h2>\n                        <h4>Chief Medical Officer<\/h4>\n                            <ul>\n<li data-zone-id=\"0\" data-line-index=\"0\" data-line=\"true\">20 years of experience in the pharmaceutical and biotechnology industries.<\/li>\n<li data-zone-id=\"0\" data-line-index=\"1\" data-line=\"true\">Served as Clinical and Medical Advisor, as well as the CMO to several biotechnology companies.<\/li>\n<li data-zone-id=\"0\" data-line-index=\"2\" data-line=\"true\">Previously held senior positions at Vifor Pharma, Ipsen and Telix.<\/li>\n<li data-zone-id=\"0\" data-line-index=\"3\" data-line=\"true\">Strong background in clinical development and regulatory affairs.<\/li>\n<li data-zone-id=\"0\" data-line-index=\"4\" data-line=\"true\">Successful launches of haematology and oncology therapies.<\/li>\n<\/ul>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30552\" idx=\"7\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/James-150x150.png\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/James-150x150.png 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/James.png 300w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><p class=\"name text-uppercase fw500\">James McDonnell<\/p>                        <p class=\"position text-capitalize fw400\">\n                            CEO                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>James McDonnell<\/h2>\n                        <h4>CEO<\/h4>\n                            <p>James McDonnell is a seasoned leader in the biopharmaceutical industry, bringing over 25 years of global experience in pharmaceuticals, with a particular focus on blood disorders and hematological malignancies such as Myeloma, Myelodysplasia, and CML.<br \/>\nThroughout his career, James has held senior leadership roles at renowned pharmaceutical companies, including Pharmion and CSL Vifor. At Pharmion, he spearheaded the growth of its oncology and hematology portfolio as Head of Global Marketing, contributing significantly to the company\u2019s acquisition by Celgene Corporation for US$2.9 billion. Most recently, James served as Global Commercial Lead for Patient Blood Management at CSL Vifor, where he drove key enterprise-wide strategic initiatives.<br \/>\nJames is a registered pharmacist and a member of the Royal Pharmaceutical Society. He holds a Graduate Diploma in Marketing from Monash University and is a graduate of the Australian Institute of Company Directors.<\/p>\n                        <\/div>\n                    <\/div>\n                                        <div class=\"team-item text-center  grid-md-4 grid-lg-5-custom  no-op   \" data-id=\"30620\" idx=\"8\">\n                        \n                        <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/05\/Bec-head-shot-BW-150x150.jpg\" class=\"vc_single_image-img attachment-thumbnail\" alt=\"\" \/><p class=\"name text-uppercase fw500\">Dr Rebecca Tunstall<\/p>                        <p class=\"position text-capitalize fw400\">\n                            Chief Operating Officer                        <\/p>\n                        \n                        <div class=\"content-info\">\n                        <h2>Dr Rebecca Tunstall<\/h2>\n                        <h4>Chief Operating Officer<\/h4>\n                            <p>Dr Rebecca Tunstall is a highly accomplished executive in the Australian biotechnology and pharmaceutical sectors, with nearly 20 years of experience in strategy, oncology product development, and operational excellence.<\/p>\n<p>Across her career, Rebecca has held pivotal leadership positions at prominent organisations including GSK, MTPConnect, and Patrys Ltd. At GSK, she built significant value over 13 years in senior oncology roles, developing deep expertise in therapeutic developmentt and commercialisation. As Senior Director of Stakeholder Engagement at MTPConnect, she orchestrated collaborative initiatives connecting Australia&#8217;s medtech and biotech ecosystem with industry and government partners. Most recently, Rebecca served as Vice President of Corporate Development at Patrys Ltd (ASX:PAB), where she executed critical business development and cross-functional initiatives.<\/p>\n<p>Rebecca holds a PhD and Bachelor of Applied Science with Honours, and is a graduate of the Australian Institute of Company Directors.<\/p>\n                        <\/div>\n                    <\/div>\n                                    \n            <\/div>\n            <div id=\"next\">\u203a  <\/div>\n            <div class=\"result grid-row\"><\/div>\n        <\/div>\n        <\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"webcast\" class=\"wp-block-gutentor-m3 section-gme9fb76f gutentor-module gutentor-container-cover has-image-bg has-custom-bg live-inves\"><div class=\"grid-container\">\n<section id=\"gmab8d4d7\" class=\"wp-block-gutentor-m4 section-gmab8d4d7 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmbb267e\" class=\"wp-block-gutentor-m4-col col-gmbb267e gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gmbb267e\" class=\"section-gmbb267e gutentor-col-wrap\">\n<h2 class=\"wp-block-heading has-white-color has-text-color has-large-font-size\">Live Investor Briefing<\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left has-white-color has-text-color has-link-color wp-elements-93da7c2b775aa195f38c2b9d8d82f685\">Prescient Therapeutics (ASX: PTX)<\/h3>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gmb2f0c78\" class=\"wp-block-gutentor-m4 section-gmb2f0c78 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm021aac\" class=\"wp-block-gutentor-m4-col col-gm021aac gutentor-single-column  grid-lg-6 grid-md-12 grid-12 space text-1\"><div id=\"section-gm021aac\" class=\"section-gm021aac gutentor-col-wrap\">\n<h4 class=\"wp-block-heading has-white-color has-text-color\" style=\"font-size:26px\">Register for an Upcoming Webcast<\/h4>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-css-opacity has-background\" style=\"background-color:#53d443;color:#53d443\"\/>\n\n\n\n<p><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\">Please join Prescient Therapeutics CEO James McDonnell for an investor briefing.<\/mark><\/p>\n\n\n\n<p><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\"><strong>In this session<\/strong>, <strong>James will discuss:<\/strong><\/mark><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-white-color has-text-color has-link-color wp-elements-0f2605ee29a094ca455280735644f654\">Our outstanding PTX-100 Phase 1b results including the <strong>64% tumor halt or reduction <\/strong>for a cancer considered a \u2018death sentence\u2019.<\/li>\n\n\n\n<li class=\"has-white-color has-text-color has-link-color wp-elements-6ebf143812b7296cc862f163152e7941\">The <strong>designations received from the FDA <\/strong>which could allow us to head toward a US$1.8bn market after Phase 2.<\/li>\n\n\n\n<li class=\"has-white-color has-text-color has-link-color wp-elements-0516572084ffed2bf93252e44ef4d298\">Why their technology could apply to <strong>22% of all cancer cases <\/strong>(Lung, Pancreas, Ovarian etc.)<\/li>\n<\/ul>\n\n\n\n<p class=\"has-white-color has-text-color\">This is a live and interactive online session, and participants are encouraged to ask questions<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-white-color\">.&nbsp;<\/mark><strong>Spots are limited, so secure yours today.<\/strong><br><br><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-light-green-cyan-color\">Can\u2019t make this time, register to receive the replay.<\/mark><\/strong><\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-normal-font-size\"><br><\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gmabc8d2\" class=\"wp-block-gutentor-m4-col col-gmabc8d2 gutentor-single-column  grid-lg-6 grid-md-12 grid-12\"><div id=\"section-gmabc8d2\" class=\"section-gmabc8d2 gutentor-col-wrap\">        <div class=\"enouvo-form only-enou custom-form show-text \">\n            <h4 class=\"form-title\" >Attend the Session<\/h4>            <!--[if lte IE 8]>\n            <script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2-legacy.js\"><\/script>\n            <![endif]-->\n            <script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2.js\"><\/script>\n            <script data-hubspot-rendered=\"true\">hbspt.forms.create({\n                portalId: \"7664250\",\n                formId: \"b50bfb3e-c115-4fd8-b074-632f5c074cef\",\n                goToWebinarWebinarKey: '',\n                formInstanceId: '',\n                    onFormSubmitted: function($form) {\n                        jQuery('.only-enou .hypelinkbkt,.only-enou .byclick').hide();\n\t\t\t\t\t\tjQuery('.only-enou .form-title').text('Thank you ');\n                    }\n            });<\/script>\n                        \n                            <a id=\"hypelinkbkt\" class=\"hypelinkbkt\" target=\"blank\" rel=\"noopener noreferrer\">What is a 708 investor?<\/a>\n            <div class=\"byclick\"><p>By clicking submit, I agree to the terms of the\u00a0<a href=\"https:\/\/reachmarkets.com.au\/financial-services-guide\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Reach Markets Financial Services Guide<\/strong><\/a>\u00a0that includes the <a href=\"https:\/\/reachmarkets.com.au\/privacy-reach\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Privacy Statement.<\/strong><\/a> Reach Markets who have been engaged by Prescient Therapeutics Limited to provide Corporate Advisory Services, including managing investor communications and may receive fees for its services.<\/p><\/div>\n                                    <\/div>\n            \n        \n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"latest-news\" class=\"wp-block-gutentor-m3 section-gm6dcb280 gutentor-module gutentor-container-cover d-none\"><div class=\"grid-container\">\n<section id=\"gm5707dcc\" class=\"wp-block-gutentor-m4 section-gm5707dcc gutentor-module gutentor-advanced-columns custom-post\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmd40cbe\" class=\"wp-block-gutentor-m4-col col-gmd40cbe gutentor-single-column  grid-lg-2 grid-md-12 grid-12\"><div id=\"section-gmd40cbe\" class=\"section-gmd40cbe gutentor-col-wrap\"><\/div><\/div>\n\n\n\n<div id=\"col-gmcd9ed6\" class=\"wp-block-gutentor-m4-col col-gmcd9ed6 gutentor-single-column  grid-lg-8 grid-md-12 grid-12 ce\"><div id=\"section-gmcd9ed6\" class=\"section-gmcd9ed6 gutentor-col-wrap\">\n<h2 class=\"wp-block-heading\"><br><strong>Company Explainer<\/strong><\/h2>\n\n\n\n<p>5 mins | 8 April, 2022<\/p>\n\n\n\n<a class=\"click-zoom btn-cp\" href=\"https:\/\/player.vimeo.com\/video\/704021373\">Watch Video<\/a>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm22fc3c\" class=\"wp-block-gutentor-m4-col col-gm22fc3c gutentor-single-column  grid-lg-2 grid-md-12 grid-12\"><div id=\"section-gm22fc3c\" class=\"section-gm22fc3c gutentor-col-wrap\"><\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"media\" class=\"wp-block-gutentor-m3 section-gmbcf8d18 gutentor-module gutentor-container-cover\"><div class=\"grid-container\">\n<section id=\"gmc587b0d\" class=\"wp-block-gutentor-m4 section-gmc587b0d gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmf08dbc\" class=\"wp-block-gutentor-m4-col col-gmf08dbc gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gmf08dbc\" class=\"section-gmf08dbc gutentor-col-wrap\">\n<h3 class=\"wp-block-heading\">Media<\/h3>\n\n\n\n<p><\/p>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gmc102e26\" class=\"wp-block-gutentor-m4 section-gmc102e26 gutentor-module gutentor-advanced-columns custom-post\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm395b8a\" class=\"wp-block-gutentor-m4-col col-gm395b8a gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm395b8a\" class=\"section-gm395b8a gutentor-col-wrap\">        <div class=\"post-grid grid-row default\" data-format=\"default\">\n                                <div class=\"grid-md-4 grid-lg-4 size-light margin post-31273 post type-post status-publish format-standard has-post-thumbnail hentry category-articles category-news tag-the-australian\" data-mb=\"35\" data-md=\"30\" >\n                        <article class=\"style2 default\">\n                            <a  href=\"https:\/\/www.theaustralian.com.au\/business\/stockhead\/content\/prescient-therapeutics-takes-cap-raise-to-98m-to-fasttrack-cancer-treatment\/news-story\/f8e118e0564588743f859d0e9fd12fab\" class=\"\">\n                            <div class=\"post-thumbnail rel\">\n                                <img loading=\"lazy\" decoding=\"async\" class=\"vc_single_image-img \" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-31-151050-359x203.png\" width=\"359\" height=\"203\" alt=\"Screenshot 2025-07-31 151050\" title=\"Screenshot 2025-07-31 151050\" \/>                                 <a class=\"tag\" href=https:\/\/template.reachmarkets.com.au\/investorportal\/tag\/the-australian\/>The Australian <\/a> \n                            <\/div>\n                            <\/a>\n                            <div class=\"post-content\">\n                                                                 <h3 class=\"post-title fw600\"><a class=\"\" href=\"https:\/\/www.theaustralian.com.au\/business\/stockhead\/content\/prescient-therapeutics-takes-cap-raise-to-98m-to-fasttrack-cancer-treatment\/news-story\/f8e118e0564588743f859d0e9fd12fab\">Prescient Therapeutics takes cap raise to $9.8m to fast-track cancer treatment<\/a><\/h3>\n                                                                 <div class=\"date style2\">July 31, 2025<\/div>                                                                \n\n                             \n                                                 \n                                <p><\/p>\n                                \n                                        \n                                                                \n                                                        \n                            <\/div>\n                        <\/article>\n                    <\/div>\n                    \n                                        <div class=\"grid-md-4 grid-lg-4 size-light margin post-31262 post type-post status-publish format-standard has-post-thumbnail hentry category-articles category-news tag-proactive-investors\" data-mb=\"35\" data-md=\"30\" >\n                        <article class=\"style2 default\">\n                            <a  href=\"https:\/\/www.proactiveinvestors.com.au\/companies\/news\/1075693\/prescient-advances-ptx-100-trial-after-fda-fast-track-nod-raises-6-8-million-for-development-1075693.html\" class=\"\">\n                            <div class=\"post-thumbnail rel\">\n                                <img loading=\"lazy\" decoding=\"async\" class=\"vc_single_image-img \" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-31-083319-359x203.png\" width=\"359\" height=\"203\" alt=\"Screenshot 2025-07-31 083319\" title=\"Screenshot 2025-07-31 083319\" \/>                                 <a class=\"tag\" href=https:\/\/template.reachmarkets.com.au\/investorportal\/tag\/proactive-investors\/>Proactive Investors <\/a> \n                            <\/div>\n                            <\/a>\n                            <div class=\"post-content\">\n                                                                 <h3 class=\"post-title fw600\"><a class=\"\" href=\"https:\/\/www.proactiveinvestors.com.au\/companies\/news\/1075693\/prescient-advances-ptx-100-trial-after-fda-fast-track-nod-raises-6-8-million-for-development-1075693.html\">Prescient advances PTX-100 trial after FDA Fast Track nod, raises $6.8 million for development<\/a><\/h3>\n                                                                 <div class=\"date style2\">July 30, 2025<\/div>                                                                \n\n                             \n                                                 \n                                <p><\/p>\n                                \n                                        \n                                                                \n                                                        \n                            <\/div>\n                        <\/article>\n                    <\/div>\n                    \n                                        <div class=\"grid-md-4 grid-lg-4 size-light margin post-31227 post type-post status-publish format-standard has-post-thumbnail hentry category-articles category-news tag-the-australian\" data-mb=\"35\" data-md=\"30\" >\n                        <article class=\"style2 default\">\n                            <a  href=\"https:\/\/www.theaustralian.com.au\/business\/stockhead\/content\/prescient-focuses-on-advancing-lead-cancer-drug-toward-pivotal-trial\/news-story\/a2b93255af2997fefbc50a592997407f\" class=\"\">\n                            <div class=\"post-thumbnail rel\">\n                                <img loading=\"lazy\" decoding=\"async\" class=\"vc_single_image-img \" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/07\/The-Aus-PTX-359x203.png\" width=\"359\" height=\"203\" alt=\"The Aus-PTX\" title=\"The Aus-PTX\" \/>                                 <a class=\"tag\" href=https:\/\/template.reachmarkets.com.au\/investorportal\/tag\/the-australian\/>The Australian <\/a> \n                            <\/div>\n                            <\/a>\n                            <div class=\"post-content\">\n                                                                 <h3 class=\"post-title fw600\"><a class=\"\" href=\"https:\/\/www.theaustralian.com.au\/business\/stockhead\/content\/prescient-focuses-on-advancing-lead-cancer-drug-toward-pivotal-trial\/news-story\/a2b93255af2997fefbc50a592997407f\">Prescient focuses on advancing lead cancer drug toward pivotal trial<\/a><\/h3>\n                                                                 <div class=\"date style2\">July 28, 2025<\/div>                                                                \n\n                             \n                                                 \n                                <p><\/p>\n                                \n                                        \n                                                                \n                                                        \n                            <\/div>\n                        <\/article>\n                    <\/div>\n                    \n                            <\/div>\n        \n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm5aa684a\" class=\"wp-block-gutentor-m4 section-gm5aa684a gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gme77987\" class=\"wp-block-gutentor-m4-col col-gme77987 gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gme77987\" class=\"section-gme77987 gutentor-col-wrap\">\n<div id=\"section-g2f5df5\" class=\"wp-block-gutentor-e2 section-g2f5df5 gutentor-element gutentor-element-button text-center fw700 ticss-55882f06\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/news-media\/\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>See all news<\/span><\/a><\/span><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"gm6f0c938\" class=\"wp-block-gutentor-m3 alignwide section-gm6f0c938 gutentor-module gutentor-container-cover has-color-bg has-custom-bg wp-tes\"><div class=\"grid-container\">\n<section id=\"gm8a4f326\" class=\"wp-block-gutentor-m4 section-gm8a4f326 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm5bbcaf\" class=\"wp-block-gutentor-m4-col col-gm5bbcaf gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm5bbcaf\" class=\"section-gm5bbcaf gutentor-col-wrap\">\n<h3 class=\"wp-block-heading\">Team Testimonials<\/h3>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm85dd3c3\" class=\"wp-block-gutentor-m4 section-gm85dd3c3 gutentor-module gutentor-advanced-columns d-none\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm45dd49\" class=\"wp-block-gutentor-m4-col col-gm45dd49 gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-left\"><div id=\"section-gm45dd49\" class=\"section-gm45dd49 gutentor-col-wrap\"><\/div><\/div>\n\n\n\n<div id=\"col-gmb26984\" class=\"wp-block-gutentor-m4-col col-gmb26984 gutentor-single-column  grid-lg-6 grid-md-12 grid-12 cp-left\"><div id=\"section-gmb26984\" class=\"section-gmb26984 gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/staging-ptx.investorportal.com.au\/wp-content\/uploads\/2025\/01\/PTX-QA-Mariam-Mansour.png\"\/><a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/1045178021\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<p>Mariam Mansour, PhD Testimonial<\/p>\n\n\n\n<p>5 December 2024<\/p>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gmc79b4ae\" class=\"wp-block-gutentor-m4 section-gmc79b4ae gutentor-module gutentor-advanced-columns custom-h3\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm1f9a74\" class=\"wp-block-gutentor-m4-col col-gm1f9a74 gutentor-single-column  grid-lg-1 grid-md-12 grid-12\"><div id=\"section-gm1f9a74\" class=\"section-gm1f9a74 gutentor-col-wrap\"><\/div><\/div>\n\n\n\n<div id=\"col-gma27582\" class=\"wp-block-gutentor-m4-col col-gma27582 gutentor-single-column  grid-lg-10 grid-md-12 grid-12\"><div id=\"section-gma27582\" class=\"section-gma27582 gutentor-col-wrap\">\n<div class=\"video-popup text-center rel\" class=\"wp-block-myblock-popup\"><img decoding=\"async\" src=\"https:\/\/staging-ptx.investorportal.com.au\/wp-content\/uploads\/2025\/01\/70948d5f-d3ba-4a58-bd5d-65b5d5d48552.png\"\/><a class=\"click-zoom\" href=\"https:\/\/player.vimeo.com\/video\/1030944188\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"54\" height=\"52\" viewBox=\"0 0 54 52\"><g fill=\"none\" fill-rule=\"evenodd\" stroke=\"none\" stroke-width=\"1\" opacity=\"0.9\"><g fill=\"#FFF\" fill-rule=\"nonzero\" transform=\"translate(-656 -2075)\"><g transform=\"translate(113 1901)\"><g transform=\"translate(0 91)\"><g transform=\"translate(390)\"><path d=\"M180 83.008c-14.378 0-26.075 11.66-26.075 25.992s11.697 25.992 26.075 25.992 26.075-11.66 26.075-25.992S194.378 83.008 180 83.008zm10.575 26.679l-16.822 11.738a.841.841 0 01-1.323-.687V97.262c0-.313.174-.6.452-.744a.845.845 0 01.871.057l16.822 11.738a.836.836 0 010 1.374z\"><\/path><\/g><\/g><\/g><\/g><\/g><\/svg><\/a><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">Prof. H. Miles Prince Testimonial<\/h4>\n\n\n\n<p>17 October 2024<\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm0fc5cb\" class=\"wp-block-gutentor-m4-col col-gm0fc5cb gutentor-single-column  grid-lg-1 grid-md-12 grid-12\"><div id=\"section-gm0fc5cb\" class=\"section-gm0fc5cb gutentor-col-wrap\"><\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gmdefb682\" class=\"wp-block-gutentor-m4 section-gmdefb682 gutentor-module gutentor-advanced-columns center\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm7487a5\" class=\"wp-block-gutentor-m4-col col-gm7487a5 gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm7487a5\" class=\"section-gm7487a5 gutentor-col-wrap\">\n<div id=\"section-g649344\" class=\"wp-block-gutentor-e2 section-g649344 gutentor-element gutentor-element-button button-align-center-desktop boxshadow button-ennou\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"https:\/\/ptxtherapeutics.com\/about-us\/\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>Learn more about the team<\/span><\/a><\/span><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm3b1b08f\" class=\"wp-block-gutentor-m3 section-gm3b1b08f gutentor-module gutentor-container-cover d-none\"><div class=\"grid-container\">\n<iframe loading=\"lazy\" class=\"pdfjs-viewer\" width=\"100%\" height=\"500\" src=\"https:\/\/staging-ptx.investorportal.com.au\/wp-content\/themes\/enouvo\/inc\/pdfjs\/web\/viewer.html?file=https:\/\/staging-ptx.investorportal.com.au\/wp-content\/uploads\/2021\/10\/RD-Presentation-Sep-21.pdf#zoom=page-fit\"><\/iframe>\n<\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"gm59e64b3\" class=\"wp-block-gutentor-m3 alignwide section-gm59e64b3 gutentor-module gutentor-container-cover has-color-bg has-custom-bg image-stay2\"><div class=\"grid-container\">\n<section id=\"gm493a6b8\" class=\"wp-block-gutentor-m4 section-gm493a6b8 gutentor-module gutentor-advanced-columns has-color-bg has-custom-bg stay\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm0f8d79\" class=\"wp-block-gutentor-m4-col col-gm0f8d79 gutentor-single-column  grid-lg-6 grid-md-12 grid-12\"><div id=\"section-gm0f8d79\" class=\"section-gm0f8d79 gutentor-col-wrap\">\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/Person-2-1.svg\" alt=\"\" class=\"wp-image-26642\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm6bbb06\" class=\"wp-block-gutentor-m4-col col-gm6bbb06 gutentor-single-column  grid-lg-6 grid-md-12 grid-12\"><div id=\"section-gm6bbb06\" class=\"section-gm6bbb06 gutentor-col-wrap\">\n<p class=\"has-white-color has-text-color has-medium-font-size\">Please join Prescient CEO James McDonnell for an investor briefing.<\/p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div id=\"section-gd8e972\" class=\"wp-block-gutentor-e2 section-gd8e972 gutentor-element gutentor-element-button button-align-left-desktop ticss-e952a764\"><span class=\"gutentor-button-wrap\"><a class=\"gutentor-button gutentor-block-button gutentor-icon-hide\" href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/investor-briefing\/\"><i class=\"gutentor-button-icon fas fa-book\"><\/i><span>Book in today<\/span><\/a><\/span><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section id=\"gm08405ab\" class=\"wp-block-gutentor-m3 alignwide section-gm08405ab gutentor-module gutentor-container-cover has-color-bg has-custom-bg\"><div class=\"grid-container\"><div class=\"form-sidebar\"><a class=\"closes\" style=\"cursor: pointer;\"><img decoding=\"async\" src=\"https:\/\/prescienttherapeutics-rebuild.investorportal.com.au\/wp-content\/uploads\/2022\/07\/close-btn.svg\"><\/a><div style=\"padding: 0 0 0 0; position: relative;\">\n<h2 class=\"the-latest-news\" style=\"color: #0089C4; text-align: left; font-size: 24px!important; margin-bottom: 5px;\">Receive email updates<\/h2>\n<p><!-- Hotjar Tracking Code for https:\/\/template.reachmarkets.com.au\/investorportal\/ --> <script> (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2736440,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https:\/\/static.hotjar.com\/c\/hotjar-','.js?sv='); <\/script> <!--[if lte IE 8]> <script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2-legacy.js\"><\/script> <![endif]--> <script  charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2.js\"><\/script> <script> hbspt.forms.create({ region: \"na1\", portalId: \"7664250\", formId: \"8be09ab6-f2b3-484c-8108-42cd66e3980d\", formInstanceId: \"slide\", onFormSubmitted: function($form) { jQuery('.byclick').hide(); gtag_report_conversion('#'); jQuery('.the-latest-news').text('Receive email updates'); } }); <\/script><a id=\"hypelinkbkt\" class=\"hypelinkbkt\" style=\"font-weight: 700; font-size: 14px;\" target=\"blank\" rel=\"noopener noreferrer\">What is a 708 investor?<\/a><\/p>\n<p class=\"byclick\" style=\"font-size: 14px !important;margin-bottom: 0px;\">By submitting this form, I agree to the terms of the&nbsp;<a class=\"md-opjjpmhoiojifppkkcdabiobhakljdgm_doc\" href=\"https:\/\/reachmarkets.com.au\/financial-services-guide\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong style=\"font-size: 14px !important;\">Reach Markets Financial Services Guide<\/strong><\/a>&nbsp;that includes the&nbsp;<a class=\"md-opjjpmhoiojifppkkcdabiobhakljdgm_doc\" href=\"https:\/\/reachmarkets.com.au\/privacy-reach\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong style=\"font-size: 14px !important;\">Privacy Statement<\/strong><\/a>. Reach Markets has been engaged by Prescient Therapeutics Limited to assist with their investor communications and may receive fees for its services.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<script>jQuery(document).ready(function($) {\n    $('#webcast .byclick').html('<p>By clicking submit, I agree to the terms of the <a href=\"https:\/\/reachmarkets.com.au\/financial-services-guide\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Reach Markets Financial Services Guide<\/strong><\/a>&nbsp;that includes the <a href=\"https:\/\/reachmarkets.com.au\/privacy-reach\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Privacy Statement.<\/strong><\/a> Reach Markets provides Corporate Advisory Services, including managing investor communications on behalf of Prescient Therapeutics Limited and may receive fees for its services.<\/p>')\n});<\/script>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":37,"featured_media":30341,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-12015","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investor Centre - PTX Therapeutics<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investor Centre - PTX Therapeutics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/template.reachmarkets.com.au\/investorportal\/\" \/>\n<meta property=\"og:site_name\" content=\"PTX Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-31T00:37:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png\" \/>\n\t<meta property=\"og:image:width\" content=\"428\" \/>\n\t<meta property=\"og:image:height\" content=\"119\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\",\"name\":\"Investor Centre - PTX Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png\",\"datePublished\":\"2021-04-12T09:03:10+00:00\",\"dateModified\":\"2025-07-31T00:37:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/template.reachmarkets.com.au\/investorportal\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png\",\"contentUrl\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png\",\"width\":428,\"height\":119},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Centre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#website\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\",\"name\":\"PTX Therapeutics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investor Centre - PTX Therapeutics","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Investor Centre - PTX Therapeutics","og_url":"https:\/\/template.reachmarkets.com.au\/investorportal\/","og_site_name":"PTX Therapeutics","article_modified_time":"2025-07-31T00:37:44+00:00","og_image":[{"width":428,"height":119,"url":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/","name":"Investor Centre - PTX Therapeutics","isPartOf":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage"},"image":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage"},"thumbnailUrl":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png","datePublished":"2021-04-12T09:03:10+00:00","dateModified":"2025-07-31T00:37:44+00:00","breadcrumb":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/template.reachmarkets.com.au\/investorportal\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#primaryimage","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png","contentUrl":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2025\/04\/Prescient.png","width":428,"height":119},{"@type":"BreadcrumbList","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/template.reachmarkets.com.au\/investorportal\/"},{"@type":"ListItem","position":2,"name":"Investor Centre"}]},{"@type":"WebSite","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#website","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/","name":"PTX Therapeutics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/template.reachmarkets.com.au\/investorportal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/pages\/12015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/comments?post=12015"}],"version-history":[{"count":734,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/pages\/12015\/revisions"}],"predecessor-version":[{"id":31272,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/pages\/12015\/revisions\/31272"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/media\/30341"}],"wp:attachment":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/media?parent=12015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}